UOTB 2025
UOTB 2025
Advertisement
Raveen Syan, MD, FPMRSUrothelial Carcinoma | January 21, 2025
Dr. Syan highlights advancements in pelvic medicine and reconstructive surgery, and progress in gender-specific challenges.
View More
Raveen Syan, MD, FPMRSUrothelial Carcinoma | January 21, 2025
Dr. Syan shares her vision for the meeting and the lessons or feedback from the past two years that helped shape the program.
Rafael Sanchez-Salas, MDLocalized | January 21, 2025
Dr. Sanchez-Salas comments on whether PSMA PET is useful for determining optimal candidates for focal therapy.
Rafael Sanchez-Salas, MDLocalized | January 21, 2025
Dr. Sanchez-Salas details strategies for selecting between focal therapy versus active surveillance or definitive treatments.
Jihad Kaouk, MDLocalized | January 21, 2025
Dr. Kaouk presented on the benefits of surgery for managing biochemically recurrent prostate cancer post-radiation.
Jihad Kaouk, MDLocalized Renal Cell Carcinoma | January 21, 2025
Dr. Kaouk explains how a multidisciplinary team should be integrated into the management of RCC.
Jose A. Karam, MD, FACSLocalized Renal Cell Carcinoma | January 21, 2025
Dr. Karam explains the main points of emphasis when it comes to small renal masses and surveillance versus surgery.
Ian Thompson, Jr., MDLocalized | January 21, 2025
Dr. Thompson, Jr. highlights his recently published large dataset of long-term complications of prostate cancer treatment.
Brian Shuch, MDRenal Cell Carcinoma Diagnostics | January 9, 2025
Dr. Brian Shuch gives a preview of Urology on the Beach 2025, including his session on molecular imaging agents.
Advertisement
Advertisement